12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Ovarex anti-ideotype vaccine data

At the International Society of Oncodevelopmental Biology and Medicine conference in Montreux, Switzerland, AXO presented data from 100 stage III and IV ovarian cancer patients who had...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >